The spontaneous azaguanine-resistant mutants of diploid human fibroblasts.

Comparative lesion sequencing provides insights into tumor evolution. Proc Natl Acad Sci U S A (2008) 10.52

Half or more of the somatic mutations in cancers of self-renewing tissues originate prior to tumor initiation. Proc Natl Acad Sci U S A (2013) 3.15

Mutational heterogeneity in human cancers: origin and consequences. Annu Rev Pathol (2010) 2.02

The mutation rate and cancer. Genetics (1998) 1.88

Elevated spontaneous mutation rate in Bloom syndrome fibroblasts. Proc Natl Acad Sci U S A (1981) 1.62

Normal diploid human and rodent cells lack a detectable frequency of gene amplification. Proc Natl Acad Sci U S A (1990) 1.55

T-cell cloning to detect the mutant 6-thioguanine-resistant lymphocytes present in human peripheral blood. Proc Natl Acad Sci U S A (1982) 1.45

Localized Derepression on the Human Inactive X Chromosone in Mouse-Human Cell Hybrids. Proc Natl Acad Sci U S A (1975) 1.43

Expression of purine overproduction in a series of 8-azaguanine-resistant diploid human lymphoblast lines. Proc Natl Acad Sci U S A (1974) 1.25

Derivation of TK- clones from revertant TK+ mammalian cells. Genetics (1973) 1.13

Genetic instability and the mutator phenotype. Studies in ulcerative colitis. Am J Pathol (1999) 1.08

Isolation and characterization of mutants of human diploid fibroblasts resistant to diphtheria toxin. Proc Natl Acad Sci U S A (1978) 1.08

Linkage relationships of X-linked enzymes glucose-6-phosphate dehydrogenase and hypoxanthine guanine phosphoribosyltransferase: recombination in female offspring of compound heterozygotes. Am J Hum Genet (1974) 0.93

Hypoxanthine-guanine phosphoribosyltransferase. Characterization of a mutant in a patient with gout. J Clin Invest (1975) 0.90

Genetic instability at the adenine phosphoribosyltransferase locus in mouse L cells. Mol Cell Biol (1982) 0.89

The in vivo rate of somatic adenomatous polyposis coli mutation. Am J Pathol (2008) 0.88

Therapeutic targeting of tumor suppressor genes. Cancer (2014) 0.82

Hypoxanthine-guanine phosphoribosyltransferase variant associated with accelerated purine synthesis. J Clin Invest (1973) 0.82

The (not so) immortal strand hypothesis. Stem Cell Res (2015) 0.76

Frequency of 6-thioguanine-resistant T cells is inversely related to the declining T-cell activities in aging mice. Proc Natl Acad Sci U S A (1986) 0.75

Virus-specific cytotoxic T-lymphocyte responses select for amino-acid variation in simian immunodeficiency virus Env and Nef. Nat Med (1999) 4.93

A class I antigen, HLA-G, expressed in human trophoblasts. Science (1990) 4.36

Gamma ray-induced loss of expression of HLA and glyoxalase I alleles in lymphoblastoid cells. Proc Natl Acad Sci U S A (1980) 4.35

A gene in the human major histocompatibility complex class II region controlling the class I antigen presentation pathway. Nature (1991) 3.87

Characterization of the peptide binding motif of a rhesus MHC class I molecule (Mamu-A*01) that binds an immunodominant CTL epitope from simian immunodeficiency virus. J Immunol (1998) 3.65

Production of human cells expressing individual transferred HLA-A,-B,-C genes using an HLA-A,-B,-C null human cell line. J Immunol (1989) 3.24

DO beta: a new beta chain gene in HLA-D with a distinct regulation of expression. EMBO J (1985) 3.20

Restored expression of major histocompatibility class I molecules by gene transfer of a putative peptide transporter. Nature (1991) 3.12

Detection of a novel human class II HLA antigen. Nature (1983) 2.61

Human placental HLA-G expression is restricted to differentiated cytotrophoblasts. J Immunol (1995) 2.54

Recognition by human V gamma 9/V delta 2 T cells of a GroEL homolog on Daudi Burkitt's lymphoma cells. Science (1990) 2.25

Transfer and expression of three cloned human non-HLA-A,B,C class I major histocompatibility complex genes in mutant lymphoblastoid cells. Proc Natl Acad Sci U S A (1988) 2.12

Single-allele expression at an X-linked hyperuricemia locus in heterozygous human cells. Proc Natl Acad Sci U S A (1968) 2.05

Mutations that impair a posttranscriptional step in expression of HLA-A and -B antigens. Proc Natl Acad Sci U S A (1985) 2.05

Expression of human genes for adenine phosphoribosyltransferase and hypoxanthine-guanine phosphoribosyltransferase after genetic transformation of mouse cells with purified human DNA. Somatic Cell Genet (1980) 1.96

Isolation of HLA locus-specific DNA probes from the 3'-untranslated region. Proc Natl Acad Sci U S A (1984) 1.93

Specificity of monoclonal antibodies directed against human and murine class II histocompatibility antigens as analyzed by binding to HLA-deletion mutant cell lines. Hum Immunol (1985) 1.92

Homozygous deletions that simultaneously eliminate expressions of class I and class II antigens of EBV-transformed B-lymphoblastoid cells. I. Reduced proliferative responses of autologous and allogeneic T cells to mutant cells that have decreased expression of class II antigens. Hum Immunol (1984) 1.83

Construction of a map of the short arm of human chromosome 6. Proc Natl Acad Sci U S A (1986) 1.80

Presentation of viral antigen by MHC class I molecules is dependent on a putative peptide transporter heterodimer. Nature (1992) 1.79

Genetic mapping of a human class II antigen beta-chain cDNA clone to the SB region of the HLA complex. Proc Natl Acad Sci U S A (1983) 1.78

HLA-E. A novel HLA class I gene expressed in resting T lymphocytes. J Immunol (1988) 1.73

Processing pathways for presentation of cytosolic antigen to MHC class II-restricted T cells. Nature (1992) 1.68

Derepression of genes on the human inactive X chromosome: evidence for differences in locus-specific rates of derepression and rates of transfer of active and inactive genes after DNA-mediated transformation. Somatic Cell Genet (1982) 1.67

A minimum of four human class II alpha-chain genes are encoded in the HLA region of chromosome 6. Nature (1983) 1.61

Class I-like HLA genes map telomeric to the HLA-A2 locus in human cells. Nature (1983) 1.60

Natural killer susceptibility of human cells may be regulated by genes in the HLA region on chromosome 6. Proc Natl Acad Sci U S A (1986) 1.56

Induction of anti-tumor cytotoxic T lymphocytes in normal humans using primary cultures and synthetic peptide epitopes. Proc Natl Acad Sci U S A (1994) 1.56

Use of HLA loss mutants to analyse the structure of the human major histocompatibility complex. Nature (1982) 1.56

Somatic cell mutation. Detection and quantification of x-ray-induced mutation in cultured, diploid human fibroblasts. Mutat Res (1973) 1.55

Demonstration by class I gene transfer that reduced susceptibility of human cells to natural killer cell-mediated lysis is inversely correlated with HLA class I antigen expression. Eur J Immunol (1989) 1.52

Mapping of class I DNA sequences within the human major histocompatibility complex. Immunogenetics (1983) 1.50

Induction of HLA class I-restricted CD8+ CTLs specific for the major outer membrane protein of Chlamydia trachomatis in human genital tract infections. J Immunol (1999) 1.44

Retracted Secretion and cell surface expression of IgG1 are impaired in human B lymphoblasts that lack HLA-A, -B, and -C antigens. Proc Natl Acad Sci U S A (1989) 1.44

Localized Derepression on the Human Inactive X Chromosone in Mouse-Human Cell Hybrids. Proc Natl Acad Sci U S A (1975) 1.43

Abnormal ornithine carbamoyltransferase in mice having the sparse-fur mutation. Proc Natl Acad Sci U S A (1976) 1.42

SB: a new HLA-linked human histocompatibility gene defined using HLA-mutant cell lines. Nature (1981) 1.40

A tetrazolium method for distinguishing between cultured human fibroblasts having eiter normal or deficient levels of glucose-6-phosphate dehydrogenase. Biochem Genet (1967) 1.39

Definition of five new simian immunodeficiency virus cytotoxic T-lymphocyte epitopes and their restricting major histocompatibility complex class I molecules: evidence for an influence on disease progression. J Virol (2000) 1.37

Serologic identification of the human secondary B cell antigens. Correlations between function, genetics, and structure. J Exp Med (1982) 1.34

Assignment of an autosomal sex reversal locus (SRA1) and campomelic dysplasia (CMPD1) to 17q24.3-q25.1. Nat Genet (1993) 1.33

Dissection of the D-region of the human major histocompatibility complex by means of induced mutations in a lymphoblastoid cell line. Hum Immunol (1983) 1.25

Transfer of cloned human class I major histocompatibility complex genes into HLA mutant human lymphoblastoid cells. Mol Cell Biol (1986) 1.22

Epitope clusters in the major outer membrane protein of Chlamydia trachomatis. Curr Opin Immunol (2001) 1.21

UDP-glucose: alpha-D-galactose-1-phosphate uridylytransferase activity in cultured human fibroblasts. Biochem Genet (1967) 1.19

The single-active-X: functional differentiation at the chromosome level. Natl Cancer Inst Monogr (1967) 1.18

Chlamydia trachomatis major outer membrane protein (MOMP) epitopes that activate HLA class II-restricted T cells from infected humans. J Immunol (1996) 1.16

Direct detection and magnetic isolation of Chlamydia trachomatis major outer membrane protein-specific CD8+ CTLs with HLA class I tetramers. J Immunol (2000) 1.11

Mosaicism of peripheral blood lymphocyte populations in females heterozygous for the Lesch-Nyhan mutation. Biochem Genet (1974) 1.10

Detection of aneuploidy in chromosomes X, Y, 13, 18 and 21 by QF-PCR in 662 selected pregnancies at risk. Mol Hum Reprod (2000) 1.08

Genetic studies of HG- PRT deficiency and the Lesch-Nyhan syndrome with cultured human cells. Fed Proc (1971) 1.07

Molecular localization of human class II MT2 and MT3 determinants. J Exp Med (1984) 1.05

Novel allele-specific, post-translational reduction in HLA class I surface expression in a mutant human B cell line. J Immunol (1994) 1.05

Molecular analysis of HLA class I and class II antigen loss mutants reveals a homozygous deletion of the DR, DQ, and part of the DP region: implications for class II gene order. Hum Immunol (1986) 1.03

T-cell epitopes in variable segments of Chlamydia trachomatis major outer membrane protein elicit serovar-specific immune responses in infected humans. Infect Immun (2000) 1.02

Specific associations of fluorescent beta-2-microglobulin with cell surfaces. The affinity of different H-2 and HLA antigens for beta-2-microglobulin. J Immunol (1988) 1.01

Allelic polymorphism and transassociation of molecules encoded by the HLA-DQ subregion. Proc Natl Acad Sci U S A (1985) 1.00

Organization of the human class I major histocompatibility complex genes. Immunol Res (1987) 0.99

A case of lipogranulomatosis Farber: some clinical and ultrastructural aspects. Eur J Pediatr (1985) 0.97

Detection of females heterozygous for the Lesch-Nyhan mutation by 8-azaguanine-resistant growth of cultured fibroblasts. J Lab Clin Med (1971) 0.96

Chromosomal organization of the human major histocompatibility complex class I gene family. J Exp Med (1989) 0.96

Hemizygous HLA mutants of lymphoblastoid cells: a new cell type for histocompatibility testing. Hum Immunol (1980) 0.94

Sequence and gene transfer analyses of HLA-CwBL18 (HLA-C blank) and HLA-Cw5 genes. Implications for the control of expression and immunogenicity of HLA-C antigens. J Immunol (1989) 0.94

Insulin binding to human B lymphoblasts is a function of HLA haplotype. Proc Natl Acad Sci U S A (1987) 0.94

Lesch-Nyhan mutation: prenatal detection with amniotic fluid cells. Science (1969) 0.94

Mutagenicity detection with human cells. J Environ Pathol Toxicol (1981) 0.93

No evidence for germline mutations in exons 5-9 of the p53 gene in 25 breast cancer families. Oncogene (1992) 0.91

Resistance of cultured human fibroblasts and other cells to purine and pyrimidine analogues in relation to mutagenesis detection. Mutat Res (1974) 0.91

Ullrich-Turner syndrome is not caused by haploinsufficiency of RPS4X. Hum Genet (1996) 0.88

Restriction of Epstein-Barr virus-specific cytotoxic T cells by HLA-A, -B, and -C molecules. Hum Immunol (1989) 0.88

Ultrastructural pathology of skin biopsy and fibroblast enzyme studies in a case of GM2-gangliosidosis with deficient hexosaminidase A and thermolabile hexosaminidase B. Neuropadiatrie (1980) 0.88

Bilateral femoral dysgenesis with micrognathia, cleft palate, anomalies of the spine and pelvis, and foot deformities. Clinical and radiological findings. Helv Paediatr Acta (1981) 0.88

Dissociation in expression of MB1/MT1 and DR1 alloantigens in mutants of a lymphoblastoid cell line. J Immunol (1983) 0.87

Atypical chronic myelogenous leukemia in a patient with trisomy 8 mosaicism syndrome. Ann Hematol (1993) 0.87

Presentation of cytosolic antigen by HLA-DR requires a function encoded in the class II region of the MHC. J Immunol (1993) 0.87

Unilateral skin lesions, cataracts, optic glioma and retardation--a variant of the epidermal nevus syndrome? Dermatologica (1982) 0.86

Purine requirement of cells cultured from humans affected with Lesch-Nyhan syndrome (hypoxanthine-guanine phosphoribosyltransferase deficiency). Proc Natl Acad Sci U S A (1969) 0.85

Evidence for chromatin structure as a regulatory determinant in HLA-DR alpha gene expression. Immunogenetics (1985) 0.85

Athelia in a female infant - heterozygous for anhidrotic ectodermal dysplasia. Clin Genet (1981) 0.85

Comparison of multiple HLA-A alleles at the DNA level by using Southern blotting and HLA-A-specific probes. J Immunol (1985) 0.84

Hydrolysis of succinyldicholine and succinylmonocholine in human serum. Mol Pharmacol (1968) 0.84

Diaminopurine-resistant mutants of cultured, diploid human fibroblasts. Genetics (1973) 0.84

Presentation of soluble antigen to human T cells by products of multiple HLA-linked loci: analysis of antigen presentation by a panel of cloned, autologous, HLA-mutant Epstein-Barr virus-transformed lymphoblastoid cell lines. Hum Immunol (1987) 0.83

Isochromosome Xq in Klinefelter syndrome: report of 7 new cases. Am J Med Genet (1996) 0.83

Quality assurance in RT-PCR-based BCR/ABL diagnostics--results of an interlaboratory test and a standardization approach. Leukemia (2000) 0.83

Human T cell receptor-gamma delta-expressing T-cell lines recognize MHC-controlled elements on autologous EBV-LCL that are not HLA-A, -B, -C, -DR, -DQ, or -DP. J Immunol (1990) 0.83

In vitro chemical mutagenesis and viral transformation of a human endothelial cell strain. Cancer Res (1981) 0.82

A temperature-sensitive glucose-6-phosphate dehydrogenase in mutant cultured human cells. Proc Natl Acad Sci U S A (1968) 0.82

The locus for human adenine phosphoribosyltransferase on chromosome no. 16. Genetics (1974) 0.82

Clonal analysis of the stepwise appearance of anchorage independence and tumorigenicity in CAK, a permanent line of mouse cells. Cancer Res (1982) 0.81

A-11: cell type-specific and single-active-X transcription controls of newly found gene in cultured human cells. Somat Cell Mol Genet (1988) 0.81

Mapping of prolactin and tumor necrosis factor-beta genes on human chromosome 6p using lymphoblastoid cell deletion mutants. Somat Cell Mol Genet (1989) 0.81

Autonomous gene expression on the human inactive X chromosome. Somatic Cell Genet (1980) 0.80

DMA and DMB are the only genes in the class II region of the human MHC needed for class II-associated antigen processing. J Immunol (1995) 0.80

Expression of RPS4X in fibroblasts from patients with structural aberrations of the X chromosome. Hum Genet (1992) 0.80

Isolation and characterization of naturally processed peptides bound by class II molecules and peptides presented by normal and mutant antigen-presenting cells. Chem Immunol (1993) 0.80

The intracellular transport of MHC class II molecules in the absence of HLA-DM. J Immunol (1995) 0.80

The effect of oxygen tension on colony formation and cell proliferation of amniotic fluid cells in vitro. Prenat Diagn (1984) 0.80

Hydrolysis of succinyldicholine by Pseudocholinesterase at low concentrations. Humangenetik (1966) 0.80